**Core tip:** We have developed recommendations focused on practices such as patient transport, surgery selection and protection requirements in the Neonatal Surgery Department, with the aim of improving treatment strategies for patients and preventing infection in medical staff during the current coronavirus disease 2019 pandemic.

INTRODUCTION
============

Since December 2019, the novel coronavirus infection has spread rapidly, posing a significant threat to global health. As a tertiary referral hospital and one of the National Clinical Research Centers for Child Health and the National Children's Medical Centers, our center provides care for a large proportion of prenatal and neonatal cases in north China and has accumulated plentiful practical experience in patient transport and treatment. Following the latest national recommendations for diagnosis and treatment of coronavirus disease 2019 (COVID-19), we have developed recommendations focusing on practices such as patient transport, surgery selection and protection requirements in the neonatal surgery department, aiming to improve treatment strategies for patients and prevent infection in medical staff during the current COVID-19 pandemic.

This recommendation is in accordance with the latest "Guideline for the Diagnosis and Treatment of COVID-19 Infections" (version 7) (National Health Committee of China)\[[@B1]\], "The Coronavirus Disease 2019 (COVID-19) Treatment Guidelines" published by the National Institutes of Health (United States) (Updated: May 12, 2020)\[[@B2]\] and other literature and experts' consensus related to COVID-19 published recently, combined with the procedures performed in the institution and our previous clinical treatment experience\[[@B3]-[@B8]\].

EPIDEMIOLOGY
============

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been identified as the seventh type of coronavirus to infect humans\[[@B9]\]. These coronaviruses are classified into four genera, based on their genome characteristics: α-CoV, β-CoV, γ-CoV and δ-CoV\[[@B10]\]. According to deep sequencing, SARS-CoV-2 belongs to β-CoV\[[@B9]\].

It is thought that SARS-CoV-2 is spread mainly through respiratory droplets or close contact\[[@B11]\]. In the later stage of infection, the virus has also been detected in anal swabs from patients, which suggests the possibility of transmission *via* the oral-fecal route\[[@B11]\]. However, there is currently no evidence of vertical transmission of SARS-CoV-2 *via* intrauterine infection in women who develop COVID-19 pneumonia. In addition, there are no reports of patients' breast milk testing positive for the virus. However, after birth a newborn is susceptible to the virus due to person-to-person spread\[[@B12]-[@B14]\].

The epidemiology of COVID-19 in neonates may have its own pattern. Droplet transmission and close contact with infected individuals are the main causes of SARS-CoV-2 infection in neonates, and most neonatal cases have been found in infected family clusters\[[@B15]\]. A study on 9 infected infants reported by Wei et al\[[@B16]\] found that all these infants belonged to a family cluster. The first infected neonate in China, a 17-day-old male infant, was reported to contract the infection *via* contact with his parents\[[@B17]\].

According to current epidemiological data, COVID-19 has an incubation period ranging from 1 to 14 d, but mainly from 3 to 7 d\[[@B18]\]. Clinical symptoms in pediatric patients are relatively milder compared with those in adult patients. Most infected children have mild clinical manifestations. They may be asymptomatic or have fever, dry cough and fatigue. Some infected children experience gastrointestinal symptoms such as nausea, vomiting and diarrhea. Most pediatric patients recover within 1--2 wk after disease onset. Few may progress to lower respiratory tract infections\[[@B6],[@B16],[@B17],[@B19]\].

Real-time reverse transcriptase polymerase chain reaction of nasal and pharyngeal swabs, sputum, blood, feces and urine specimens can be used for the diagnosis of COVID-19\[[@B20]\]. A chest computed tomography (CT) scan can help physicians monitor disease changes and evaluate therapeutic effects\[[@B21]\].

HOSPITAL ADMISSIONS IN THE NEONATAL SURGERY DEPARTMENT DURING THE COVID-19 PANDEMIC
===================================================================================

Neonates can develop a range of complex and diverse diseases mainly involving hereditary factors and other abnormalities. As a result of their anatomical and physiological characteristics (especially their immature immunity), neonate diseases progress quickly. Without timely treatment these patients can deteriorate within a short time with high mortality. Due to the advances in prenatal diagnostic techniques, more and more patients who require surgical treatment, such as those with congenital diaphragmatic hernia, congenital intestinal atresia and omphalocele, can be detected by antenatal ultrasonography. Patients admitted to the hospital are mainly transferred from outpatient services, emergency departments and other hospitals.

Emergency and outpatient admissions
-----------------------------------

The evaluation and management process of patients in the emergency and outpatient departments is as follows.

Only one parent is allowed to accompany a child into the consulting room; body temperature and medical history are taken at the entrance.

All patients with suspected COVID-19 should attend the febrile outpatient or COVID-19 clinic before visiting the neonatal surgery clinic. Patients with symptoms such as nausea, vomiting and diarrhea due to diseases such as congenital hypertrophic pyloric stenosis, Hirschsprung disease and congenital intestinal malrotation should be differentiated from COVID-19 patients. We recommend real-time reverse transcriptase polymerase chain reaction and a chest CT scan for patients with suspected COVID-19 in addition to routine examinations. COVID-19 pneumonia manifests with chest CT imaging abnormalities early and in asymptomatic patients. Multiple patchy ground glass opacities in bilateral multiple lobular with periphery distribution are typical chest CT imaging features of the COVID-19 pneumonia\[[@B22]\]. Combining assessment of imaging features with clinical and laboratory findings could facilitate early diagnosis of COVID-19 pneumonia\[[@B21]\]. Patients definitively diagnosed with emergency surgical conditions should be admitted as soon as possible for further treatment. Patients who test positive for SARS-CoV-2 or those highly suspected of having COVID-19 should be transferred to a designated medical institution immediately and should be reported to the local Center for Disease Control and Prevention (Figure [1](#F1){ref-type="fig"}).
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Patients transferred from other hospitals (interhospital consultation and referral practices)
---------------------------------------------------------------------------------------------

Patients diagnosed prenatally with abnormalities that require surgery, such as congenital diaphragmatic hernia, congenital intestinal atresia, meconium peritonitis and omphalocele, who were born in nonepidemic areas and had no contact with COVID-19 patients, can be transferred under general protection and treated with routine procedures. If patients are in an unstable condition and require emergency surgery, such as for severe congenital diaphragmatic hernia and omphalocele, neonatal surgeons should wait in the delivery room/operating room and perform the operation immediately or transfer the patients to appropriate medical institutions for further treatment after delivery under intensive care and monitoring. For children in a stable condition who require elective surgical treatment, we suggest a remote consultation with neonatal specialists and give conservative treatment and support until the appropriate operation can be performed.

Patients who had a history of epidemiological exposure to COVID-19 or were born in epidemic areas should be transferred to and treated in designated medical institutions for COVID-19. Although there is no evidence of intrapartum transmission, special attention is required to prevent infection in babies born to mothers with COVID-19 pneumonia. Admitting pregnant women with laboratory-confirmed COVID-19 pneumonia to designated medical institutions for COVID-19 and advance notification to the neonatal surgical team before delivery are suggested if the neonates were prenatally diagnosed with conditions that require surgery after birth. According to the proposed management of COVID-19 during pregnancy and puerperium in China, mothers with COVID-19 pneumonia should deliver in a negative pressure ward/operating room. It is recommended that ligation of the umbilical cord is performed early, and the cord is not squeezed. All medical staff should perform these procedures under protection including the use of personal protective equipment (*e.g*., N95 respirators, face shields, gloves, goggles and gowns)\[[@B2]\] (Figure [2](#F2){ref-type="fig"}).
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NEONATAL SURGICAL WARD MANAGEMENT
=================================

Most of the neonatal surgical wards are nonescort wards, and it is better to temporarily cancel parent visiting during the COVID-19 outbreak. In escort wards, only one nucleic acid test-negative patient is allowed in the room. Neonatal care that requires family support such as feeding by the mother and kangaroo care should be suspended. In areas with severe outbreaks, it is suggested that receiving breast milk from outside the hospital should be canceled.

A quarantine chamber is necessary for suspected COVID-19 patients who are identified during the hospitalization period. Quarantine in negative pressure infectious disease wards or airborne infection isolation rooms is approved in principle. A ward with an independent air circulation system is acceptable when negative pressure rooms or airborne infection isolation rooms are unavailable. The babies are placed in warm boxes and cared for by designated medical staff. Infants who test positive for SARS-CoV-2 are immediately transferred to a designated medical institution and other babies in the same ward are isolated and undergo nucleic acid testing. The body temperature of all infants and medical staff in the ward is measured, and anyone who develops fever, dry cough and fatigue is isolated. The living zone in the ward should be independent of the working zone. All clinical procedures should be performed by medical personnel wearing protective equipment such as medical masks and protective hats. It is worth mentioning that hand hygiene is extremely important for the prevention of nosocomial infection.

PREVENTION AND CONTROL STRATEGIES IN THE PERIOPERATIVE PERIOD DURING THE COVID-19 PANDEMIC
==========================================================================================

As the majority of operations in the Neonatal Surgery Department are emergency procedures and limited surgery, suspending operations completely is unrealistic. Children with emergency conditions and low risk (no exposure history or symptoms) can be treated using routine procedures. High-risk children (suspected cases) and those with confirmed COVID-19 pneumonia should be transferred to and treated in a designated hospital as suggested above. If there is not enough time for transport or the transfer service is unavailable, surgeons can perform the surgery in a negative pressure operating room in cooperation with the Department of Anesthetics (Figure [3](#F3){ref-type="fig"}).
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We recommend for children who require selective/limited operations that the appropriate time for the operation is decided by the surgeons in coordination with the child's guardians based on the surgeons' opinion and local COVID-19 severity.

Preparation and transport before and after surgery
--------------------------------------------------

Strategies for transport of patients with suspected or diagnosed SARS-CoV-2 infection should be formulated in advance. The strategies should be reviewed by an expert committee consisting of specialists in pediatric surgery, anesthesiology, pneumology, infectious disease, radiology and the operating room. Preoperative consultation needs to consider details including transport and hand over of care, surgical program, anesthesia process, organization of the operating suite, transport routes, medical staff protection and environmental disinfection.

Anesthesia management in pediatric populations with suspected or diagnosed SARS-CoV-2 infection
-----------------------------------------------------------------------------------------------

Anesthesiologists support most neonatal patients with endotracheal intubation following general anesthesia. Anesthesiologists performing these procedures in patients with SARS-CoV-2 infection require level 3 protection. We suggest placing a disposable filter between the anesthesia breathing circuit and the endotracheal tube in order to reduce pollution\[[@B23]\]. It would be better to achieve intubation by video laryngoscopy if it is available. Moderate sedation and appropriate muscle relaxation before induction are critical for minimizing virus spread through respiratory droplets from coughs. Adaptation of high frequency, small tidal volume ventilation with limited pressure models or high frequency oscillatory ventilation is necessary to avoid pulmonary barotrauma and reduce virus spread. It is highly recommended that a closed endotracheal suction system is used to clear secretions within the endotracheal tube during and after surgery. It is necessary to ensure that patients meet the criteria for returning to the quarantine ward or pediatric intensive care unit before leaving the operating room. Patients should wear masks with nasal catheter oxygen, or they can be escorted by ventilators. All drugs and devices used should be marked and stored in designated areas after disinfection.

Management of medical personnel involved in surgery
---------------------------------------------------

If there are any exposure incidents during surgery, a 14 d medical monitor is recommended. Nucleic acid testing is necessary for those who develop symptoms.

POSTOPERATIVE MANAGEMENT OF CHILDREN
====================================

Postoperative management of children with no exposure history
-------------------------------------------------------------

Children with no exposure history or symptoms can return to the pediatric intensive care unit for further treatment, and it is suggested that parent visiting is canceled. In escort wards, only one nucleic acid test-negative patient is allowed in each room. Body temperature is measured in all infants and parents in the ward twice a day\[[@B7]\]. Those who develop fever, dry cough and fatigue should be isolated and undergo nucleic acid testing for SARS-CoV-2 and a chest CT scan.

Postoperative management of children who tested positive for SARS-CoV-2 or are highly suspected of having COVID-19
------------------------------------------------------------------------------------------------------------------

As suggested above, children with confirmed COVID-19 pneumonia should be transferred to and treated in designated medical institutions. All daily clinical procedures should be performed by medical personnel wearing appropriate personal protective equipment.

Oxygen therapy and nebulizer therapy are recommended for patients with mild to moderate hypoxemia. For severe and critical patients with respiratory distress, high-flow nasal cannula oxygen therapy, noninvasive or invasive mechanical ventilation and even extracorporeal membrane oxygenation should be considered\[[@B2]\].

Special attention should be paid to organ protection and supportive treatments as there are reports that SARS-CoV-2 may damage the liver, kidneys and myocardium to some extent. The signs to look for are elevated levels of aminotransferases, increased serum creatinine, blood urea nitrogen, creatine kinase and myoglobin as well as troponin in critical patients\[[@B20],[@B24],[@B25]\].

Early enteral feeding is generally preferred in ill children. Adequate protein delivery is also associated with fewer ventilator days and reduced mortality after adjusting for illness severity\[[@B26]\]. Enteral microbial agents can be used in selected patients.

Children, especially those receiving corticosteroids, are susceptible to secondary infections due to their incomplete immunity. In addition, those who receive mechanical ventilation are susceptible to ventilator-associated pneumonia. According to the Guideline for the diagnosis and treatment of COVID-19 infections (version 7) issued by the National Health Commission of China\[[@B1]\], inappropriate and unnecessary use of antimicrobial therapy, especially an irrational combination use of broad spectrum antibiotics is not advised. The administration of empiric antimicrobial agents should be considered when bacterial pneumonia or sepsis is suspected (*e.g*., the procalcitonin levels increase) or sputum or blood specimens show clear evidence of etiology. It is, of course, advisable to timely adjust the drug according to antimicrobial drug susceptibility test results and de-escalate or stop antibiotics if there is no evidence of bacterial infection.

According to The Coronavirus Disease 2019 (COVID-19) Treatment Guidelines published by National Institutes of Health, except in the context of a clinical trial, the COVID-19 Treatment Guidelines Panel recommends against the use of non-SARS-CoV-2-specific intravenous immunoglobulin for the treatment of COVID-19\[[@B2]\].

CRITERIA FOR DEREGULATING QUARANTINE AND DISCHARGE
==================================================

According to the Guideline for the Diagnosis and Treatment of COVID-19 Infections (version 7) issued by the National Health Commission of China, the criteria for deregulating quarantine procedures are normal body temperature for more than 3 d; significant improvement in respiratory symptoms; marked absorption of acute exudative lesions on radiological images; and two consecutive negative nucleic acid test results of samples such as nasal and pharyngeal swabs and sputum with a sampling interval at least 24 h. Patients who meet all the above criteria can discharge from quarantine and then leave the hospital when they meet the discharge criteria for their own surgical conditions.

SEVERAL CAVEATS NEED TO BE CONSIDERED AFTER DISCHARGE
=====================================================

These caveats include remaining in contact with the local primary medical institutions in the patient's place of residence and tracking the patient's condition. Also monitoring the health of the child for 14 d and ensuring family care is provided by one healthy person is recommended.

Mask wearing is encouraged. Hand hygiene, personal protection and disinfection of the baby's equipment after use are required. Upon discharge, we encourage the patients to revisit the hospital every 2 wk for the 1^st^ mo for follow-up.

Considering the good prognosis of neonates during the COVID-19 pandemic, the involvement of a multidisciplinary team consisting of specialists in obstetrics, maternal-fetal medicine and pediatrics in adjusting the prevention and control strategies for antenatal, intrapartum and postpartum diagnosis, care and treatment, is highly recommended.
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